Strong Conflict of Interest Policies are not Associated With Decreased Industry Payments to Academic Urology Departments



      To identify whether institutions with strong conflicts of interest (COI) policies receive less industry payments than those with weaker policies. While industry-physician interactions can have collaborative benefits, financial COI can undermine preservation of the integrity of professional judgment and public trust. To address this concern, academic institutions have adopted COI policies. It is unclear whether the strength of COI policy correlates with industry payments in urology.

      Materials and Methods

      131 US academic urology programs were surveyed on their COI policies, and graded according to the American Medical Student Association (AMSA) criteria. Strength of COI policy was compared against industry payments in the Center for Medicare and Medicaid Services Open Payments database.


      Fifty-seven programs responded to the survey, for a total response rate of 44%. There was no difference between COI policy groups on total hospital payments (P = .05), total department payments (P = .28), or dollars per payment (P = .57). On correlation analysis, there was a weak but statistically nonsignificant correlation between AMSA Industry Policy Survey Score and Open Payments payments (ρ = −0.14, P = .32).


      Strength of conflicts of interest policy in academic urology did not correlate to industry payments within the Open Payments database. Establishment of strong COI policy may create offsetting factors that mitigate the intended effects of the policy. Further studies will be required to develop the evidence base for policy design and implementation across various specialties.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Lo B, Field MJ. Conflict of Interest in Medical Research, Education, and Practice. National Acadamies Press, 2009.

        • Carlat D.J.
        • Fagrelius T.
        • Ramachandran R.
        • et al.
        The updated AMSA scorecard of conflict-of-interest policies: a survey of U.S. medical schools.
        BMC Med Educ. 2016; 16: 202
        • Cvetanovich GL
        • Chalmers PN
        • Bach Jr., BR
        Industry financial relationships in orthopaedic surgery: analysis of the Sunshine Act open payments database and comparison with other surgical subspecialties.
        J Bone Joint Surg Am. 2015; 97: 1288
        • Bandari J
        • Turner 2nd, RM
        • Jacobs BL
        • et al.
        Urology payments from industry in the Sunshine Act.
        Urol Pract. 2016; 3: 332
        • Grundy Q
        • Habibi R
        • Shnier A
        • et al.
        Decoding disclosure: comparing conflict of interest policy among the United States, France, and Australia.
        Health Policy. 2018; 122: 509
        • Kanter GP
        • Loewenstein G
        Evaluating open payments.
        JAMA. 2019; 322: 401-402
        • Mas A
        Does Disclosure Affect CEO Pay Setting? Evidence from the Passage of the 1934 Securities and Exchange Act.
        Princeton University, Princeton, NJ2016
        • Loewenstein G
        • Sah S
        • Cain DM
        The unintended consequences of conflict of interest disclosure.
        JAMA. 2012; 307: 669
        • Cook DA
        • Wittich CM
        • Daniels WL
        • et al.
        Incentive and reminder strategies to improve response rate for internet-based physician surveys: a randomized experiment.
        J Med Internet Res. 2016; 18: e244